CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.
about
The immune microenvironment in Hodgkin lymphoma: T cells, B cells, and immune checkpointsLymphocyte-activation gene-3, an important immune checkpoint in cancerImmune Checkpoint Modulators: An Emerging Antiglioma ArmamentariumBeyond CTLA-4 and PD-1, the Generation Z of Negative Checkpoint RegulatorsRole of immune escape mechanisms in Hodgkin's lymphoma development and progression: a whole new world with therapeutic implicationsDiacylglycerol Kinases (DGKs): Novel Targets for Improving T Cell Activity in CancerA phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinomaInfluence of ipilimumab on expanded tumour derived T cells from patients with metastatic melanoma.Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates.Lymphocyte activation gene-3 expression defines a discrete subset of HIV-specific CD8+ T cells that is associated with lower viral loadLAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors.The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells.PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in miceExpression of a broad array of negative costimulatory molecules and Blimp-1 in T cells following priming by HIV-1 pulsed dendritic cells.Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.LAG-3 regulates plasmacytoid dendritic cell homeostasisElevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells.T cell exhaustion during persistent viral infections.Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcomaUpdate on hepatitis C virus-specific immunityAnticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25.LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer modelCD28 Deficiency Enhances Type I IFN Production by Murine Plasmacytoid Dendritic Cells.Advances in targeting cell surface signalling molecules for immune modulationTumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phaseNovel Foxp3(-) IL-10(-) Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo.Costimulatory and coinhibitory receptors in anti-tumor immunityInhibitory receptors on lymphocytes: insights from infectionsMolecular signatures of T-cell inhibition in HIV-1 infection.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.VISTA is a novel broad-spectrum negative checkpoint regulator for cancer immunotherapy.Comparative Analysis of Immune Checkpoint Molecules and Their Potential Role in the Transmissible Tasmanian Devil Facial Tumor Disease.LAG-3 Confers a Competitive Disadvantage upon Antiviral CD8+ T Cell Responses.Multiple Inhibitory Pathways Contribute to Lung CD8+ T Cell Impairment and Protect against Immunopathology during Acute Viral Respiratory InfectionLymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo.Tim-3, Lag-3, and TIGIT.Treg-specific IL-27Rα deletion uncovers a key role for IL-27 in Treg function to control autoimmunity.Description of CD8 Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer
P2860
Q26745842-8DE4D184-EC8F-4ADC-959E-C8FCE25ECB23Q26746209-D44C9548-629F-4B23-B920-A093F0272F8FQ26765459-890E5EB2-05E9-4D4D-9787-04A13FF78F33Q26782799-8543AA2B-A083-45CE-B417-33B9BA5C2C44Q27011510-DC431064-EFFD-4F02-801E-0B41B14ECF07Q28069966-7AF835AB-804C-4D00-BFFF-B41C3BEEBFA6Q30412791-F88A4358-60C9-4487-B4B5-F58AF80C025CQ33688931-D5D9CD6F-6658-4C69-870B-884F7AF9C755Q34166913-2E1B8A98-9444-49FD-BD4B-E1E91311B6D6Q34381879-6A95E9BA-C87B-4ECC-8254-039950EC53EDQ34395893-0069C230-3D84-4BCC-A47C-488F7DD9F5BFQ34417483-102D32C1-B642-4EBC-A4B9-B2D0753B8A7AQ34577678-C3BF7ACE-FD08-48A6-A122-B38B42A968A3Q34699537-FCA5A35B-CD10-4651-B5F8-180EEAED2C25Q34891171-A9E98D2A-E10B-4254-9571-76E7930CCF27Q34939924-D33BA655-A314-448F-91C8-1F6904015551Q35096435-3CA935B7-195C-4509-8F9D-2E2CD243EF39Q35329234-67BE7E00-E39F-4490-A34C-C470372E42FBQ35582265-75131703-C815-4D8F-82E0-582E94110EFFQ35624496-45FE5A28-3B20-416B-A17F-7DBA5ED4EA6DQ35839496-A27B788D-B78D-4478-A6BB-94A55FD59596Q36293343-513B5E5E-E5D2-4BF2-B53A-B415ADF467B5Q36413772-851741C9-80FE-411D-B3C0-2254DF9962B2Q36553658-8C0780F5-9BAE-42D0-B7B6-54D9AF7DEC2DQ36973787-3A96B1FA-4030-42D7-8028-83327705C666Q37017472-6086C47C-4726-4144-B19B-240FAD5E0A50Q37223511-603CACCC-948B-41A0-AC14-225B97810ED3Q37474920-CBD6687A-F0BF-4DCF-BA78-16E5869A767DQ37996395-65F08E1A-0D89-42A5-9066-B4E9D68735D6Q38091548-045E3C16-ECF4-44C7-B9D5-60AD2C340DC7Q38636569-425BE3FF-579D-446A-AEC0-9D017C80AC4AQ38837469-52540D74-1E51-4B94-81CA-72AD2218D443Q39181190-78768151-A6A9-422C-8853-BA8D8A813EE6Q39313794-D5F8C772-EA38-4AAD-85E2-3A09AD101750Q39748865-3CDB5BA0-5591-4B8A-8413-F471CFC926BDQ40646507-17861C75-B476-46E4-90C8-B8E36554F51DQ42976150-29753A06-5D19-4808-B802-8C1DC8A4AAB1Q50125564-D054B792-CD10-4BA1-8FCB-88D1C4BB2ECEQ50219526-4E92E4D6-ECF7-4A5D-A04A-116C41528DA8Q56890349-C687810F-E5E5-4A88-A09C-8D2D82977AC5
P2860
CD3/TCR complex-associated lymphocyte activation gene-3 molecules inhibit CD3/TCR signaling.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@ast
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@en
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@nl
type
label
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@ast
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@en
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@nl
prefLabel
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@ast
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@en
CD3/TCR complex-associated lym ...... les inhibit CD3/TCR signaling.
@nl
P2093
P1476
CD3/TCR complex-associated lym ...... ules inhibit CD3/TCR signaling
@en
P2093
P304
P407
P577
1998-10-01T00:00:00Z